Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access hidradenitis suppurativa specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa treatment provided free
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)
Sponsor: Zura Bio Inc
Check if you qualify for this hidradenitis suppurativa clinical trial in Irvine, CA
If you're searching for hidradenitis suppurativa treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.